Daniel de Boer
Chief Executive Officer presso PROQR THERAPEUTICS N.V.
Patrimonio netto: 2 M $ in data 31/03/2024
Profilo
Daniel Anton de Boer is the founder of ProQR Therapeutics NV, PC Basic B.V., and Running It.
He held the position of Chief Executive Officer at each of these companies.
Additionally, he is also the founder of Amylon Therapeutics BV.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
PROQR THERAPEUTICS N.V.
0.87% | 31/12/2023 | 705 309 ( 0.87% ) | 2 M $ | 31/03/2024 |
Posizioni attive di Daniel de Boer
| Società | Posizione | Inizio |
|---|---|---|
| PROQR THERAPEUTICS N.V. | Chief Executive Officer | 21/02/2012 |
Precedenti posizioni note di Daniel de Boer
| Società | Posizione | Fine |
|---|---|---|
| Running It | Chief Executive Officer | 01/09/2011 |
| PC Basic B.V. | Chief Executive Officer | 01/02/2008 |
Amylon Therapeutics BV
 Amylon Therapeutics BV Pharmaceuticals: MajorHealth Technology Amylon Therapeutics BV is a biopharmaceutical company, which engages in the research and development of therapies for the central nervous system. It specializes in ribonucleic acid modulation technology to target rare genetic disorders. The company was founded by Thomas de Vlaam and is headquartered in Leiden, the Netherlands. | Founder | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| PROQR THERAPEUTICS N.V. | Health Technology |
| Aziende private | 3 |
|---|---|
| PC Basic B.V. | |
| Running It | |
Amylon Therapeutics BV
Amylon Therapeutics BV Pharmaceuticals: MajorHealth Technology Amylon Therapeutics BV is a biopharmaceutical company, which engages in the research and development of therapies for the central nervous system. It specializes in ribonucleic acid modulation technology to target rare genetic disorders. The company was founded by Thomas de Vlaam and is headquartered in Leiden, the Netherlands. | Health Technology |
- Borsa valori
- Insiders
- Daniel de Boer
